1. Home
  2. GPCR vs BWLP Comparison

GPCR vs BWLP Comparison

Compare GPCR & BWLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • BWLP
  • Stock Information
  • Founded
  • GPCR 2016
  • BWLP 1935
  • Country
  • GPCR United States
  • BWLP Singapore
  • Employees
  • GPCR N/A
  • BWLP N/A
  • Industry
  • GPCR
  • BWLP Marine Transportation
  • Sector
  • GPCR
  • BWLP Consumer Discretionary
  • Exchange
  • GPCR Nasdaq
  • BWLP Nasdaq
  • Market Cap
  • GPCR 1.8B
  • BWLP 1.8B
  • IPO Year
  • GPCR 2023
  • BWLP N/A
  • Fundamental
  • Price
  • GPCR $27.03
  • BWLP $10.49
  • Analyst Decision
  • GPCR Buy
  • BWLP
  • Analyst Count
  • GPCR 6
  • BWLP 0
  • Target Price
  • GPCR $85.67
  • BWLP N/A
  • AVG Volume (30 Days)
  • GPCR 797.2K
  • BWLP 553.8K
  • Earning Date
  • GPCR 11-13-2024
  • BWLP 01-01-0001
  • Dividend Yield
  • GPCR N/A
  • BWLP 28.31%
  • EPS Growth
  • GPCR N/A
  • BWLP 17.09
  • EPS
  • GPCR N/A
  • BWLP 3.59
  • Revenue
  • GPCR N/A
  • BWLP $3,601,810,000.00
  • Revenue This Year
  • GPCR N/A
  • BWLP N/A
  • Revenue Next Year
  • GPCR N/A
  • BWLP $1.46
  • P/E Ratio
  • GPCR N/A
  • BWLP $3.06
  • Revenue Growth
  • GPCR N/A
  • BWLP 38.21
  • 52 Week Low
  • GPCR $29.48
  • BWLP $10.11
  • 52 Week High
  • GPCR $62.74
  • BWLP $22.31
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 35.94
  • BWLP 30.82
  • Support Level
  • GPCR $30.81
  • BWLP $10.11
  • Resistance Level
  • GPCR $36.42
  • BWLP $11.99
  • Average True Range (ATR)
  • GPCR 2.10
  • BWLP 0.31
  • MACD
  • GPCR -0.15
  • BWLP -0.13
  • Stochastic Oscillator
  • GPCR 25.07
  • BWLP 15.63

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.

About BWLP BW LPG Limited Common Shares

BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.

Share on Social Networks: